Albert Cha

Albert Cha, M.D., Ph.D. is the Chairman of the Board at Ascendis Pharma A/S, a position he has held since May 2021.1 He has been a member of the company's board of directors since November 2014.1

Professional Background

Dr. Cha is currently a Managing Partner at Frazier Life Sciences, where he focuses on investing in biopharmaceutical and medical device companies.13 He has over 20 years of experience in this field, having previously served as a Managing Partner at Vivo Capital.1

Board Positions

In addition to his role at Ascendis Pharma, Dr. Cha serves on the board of directors of KalVista Pharmaceuticals (NASDAQ: KALV).12 He has also held board positions at several other biopharmaceutical companies, including:

• Aclaris Therapeutics (NASDAQ: ACRS)
• Biohaven Pharmaceuticals (NYSE: BHVN)
• Sierra Oncology, Inc. (NASDAQ: SRRA)2

Education and Expertise

Albert Cha holds both an M.D. and a Ph.D., indicating his strong background in medical and scientific fields.1 His expertise lies in the biopharmaceutical and medical device sectors, where he has made significant contributions as an investor and board member.13

Industry Involvement

Dr. Cha is known for his active participation in the healthcare investment community. He is a co-founder of the annual Dermatology Summit and Dermatology Innovation Forum, demonstrating his commitment to advancing innovation in the field.1

LinkedIn Profile

Albert Cha's LinkedIn username is albert-cha-a605956, and his profile lists his current position as Managing Partner at Frazier Life Sciences, based in Copenhagen, Capital Region, Denmark.3